U.S. FDA approves Merck insomnia drug

Baltimore Sun: ASHINGTON (Reuters) - The U.S. Food and Drug Administration said on Wednesday it has approved a new insomnia drug made by Merck & Co.

The drug, to be called Belsomra, is the first in a new class of sedatives that block chemicals in the brain called orexins that help keep people awake.

Read article